• Reeshoop 1, D-22926 Ahrensburg
  • Mo. - Fr. 09:00 - 16:00
  • sales@ultimed.org
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
page
presse
produkte
Facebook Deutsch English Belgian
  • Home
  • Products
    • Rapid Tests
    • Hometests
    • Covid-19, Infl. A/B & RSV Tests
    • Security Solutions
    • Supplies
  • Press
  • News
  • Company Profile
    • Team
  • Certificates
  • Contact
Ultimed
Ultimed

Do you have questions?

We are looking forward to welcoming you!

+49 (0) 4102 800 90
sales@ultimed.org

Vorschaubild: Vorschaubild: Vorschaubild: Vorschaubild:

Multi-Drug-Saliva Test

Article ID
008SXXX
manufacturer
ulti med Products (Deutschland) GmbH
Handling time
1-2 weekdays /
SHARE:
Facebook
Twitter
Share with E-Mail
Instagram

Product description

A rapid screening test for the simultaneous, qualitative detection of multiple drugs and metabolites in human oral fluid.
For professional in vitro diagnostic use only.

INTENDED USE
The SalivaScreen is a lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and their metabolites in oral fluid.

The SalivaScreen provides onyl a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtaon a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS) are the preferred confirmatory methods. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. Test to monitor therapeutic measures.

PRINCIPLE
The SalivaScreen is an immunoassay based on the principle of competitive binding. Drugs that may be present in the oral fluid specimen compete against their respective drug conjugate for binding sites on their specific antibody.
During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible coloured line will show up in the test line region of the specific drug strip. The presence of drug above the cut-off concentration in the oral fluid specimen will saturate all the binding sites of the antibody. Therefore, the coloured line will not form in the test line region.
A drug-positive oral fluid specimen will not generate a coloured line in the specific test line region of the strip because of drug competition, while a drug- negative oral fluid specimen will generate a line in the test line region because of the absence of drug competition.
To serve as a procedural control, a coloured line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.


SHARE:
Facebook
Twitter
Share with E-Mail
Instagram

  • Ultimed folgen
  • Ultimed folgen
  • Ultimed folgen
  • Ultimed folgen
  • Ultimed folgen

Sitemap

  • Company Profile
  • News
  • Home
  • Press
  • Contact
  • Imprint
  • General terms and conditions
  • Data protection notice
  • Home
  • Products
    • Rapid Tests
    • Hometests
    • Covid-19, Infl. A/B & RSV Tests
    • Security Solutions
    • Supplies
  • Press
  • News
  • Company Profile
    • Team
  • Certificates
  • Contact

Revision: 12. September 2019